Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase <scp>III</scp> randomized, double‐blind, placebo‐controlled trial
Summary Purpose Brivaracetam ( BRV ) is a novel high‐affinity synaptic vesicle protein 2A ligand currently being investigated for the treatment of epilepsy. The purpose of this phase III study was to evaluate the efficacy and safety/tolerability of adjunctive BRV in adults with uncontrolled partial‐...
Saved in:
Main Authors: | , , , , , |
---|---|
格式: | Artigo |
語言: | 英语 |
出版: |
2013
|
在線閱讀: | https://doi.org/10.1111/epi.12433 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.12433 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|